Cargando…
Chromone-embedded peptidomimetics and furopyrimidines as highly potent SARS-CoV-2 infection inhibitors: docking and MD simulation study
BACKGROUND: COVID-19 is a respiratory illness caused by SARS-CoV-2. Pharmaceutical companies aim to control virus spread through effective drugs. This study investigates chromone compound derivatives’ ability to inhibit viral entry and prevent replication. METHOD: This study investigated the inhibit...
Autores principales: | Shakibay Senobari, Zahra, Masoumian Hosseini, Mohsen, Teimouri, Mohammad Bagher, Rezayan, Ali Hossein, Samarghandian, Saeed, Hekmat, Azadeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10515067/ https://www.ncbi.nlm.nih.gov/pubmed/37735703 http://dx.doi.org/10.1186/s13104-023-06508-7 |
Ejemplares similares
-
Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents
por: Aziz, Marwa A., et al.
Publicado: (2016) -
Identification of potent chromone embedded [1,2,3]-triazoles as novel anti-tubercular agents
por: Nalla, Viswanadh, et al.
Publicado: (2018) -
Linear peptidomimetics as potent antagonists of Staphylococcus aureus agr quorum sensing
por: Karathanasi, Georgia, et al.
Publicado: (2018) -
Structural and Functional Basis of Potent Inhibition
of Leishmanial Leucine Aminopeptidase by Peptidomimetics
por: Bhat, Saleem Yousuf, et al.
Publicado: (2021) -
Discovery of Potent Peptidomimetic Antagonists for
Heterochromatin Protein 1 Family Proteins
por: Lamb, Kelsey N., et al.
Publicado: (2021)